Pseudomonas aeruginosa (PA) infections pose a serious threat to human health. PA is a leading cause of fatal lung infections in cystic fibrosis and immunesuppressed patients, of sepsis in burn victims and of nosocomial infections. An important element in PA virulence is its ability to establish biofilms that evade suppression by the host's immune system and antibiotics. PstS, a periplasmic subunit of the Pst phosphate-transport system of PA, plays a critical role in the establishment of biofilms. In some drug-resistant PA strains, PstS is secreted in large quantities from the bacteria, where it participates in the assembly of adhesion fibres that enhance bacterial virulence. In order to understand the dual function of PstS in biofilm formation and phosphate transport, the crystal structure of PA PstS was determined. Here, the overexpression in Escherichia coli and purification of PA PstS in the presence of phosphate are described. Two crystal forms were obtained using the vapour-diffusion method at 20 C and X-ray diffraction data were collected. The first crystal form belonged to the centred orthorhombic space group C222 1 , with unit-cell parameters a = 67.5, b = 151.3, c = 108.9 Å . Assuming the presence of a dimer in the asymmetric unit gives a crystal volume per protein weight (V M ) of 2.09 Å 3 Da À1 and a solvent content of 41%. The second crystal form belonged to the primitive orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 35.4, b = 148.3, c = 216.7 Å . Assuming the presence of a tetramer in the asymmetric unit gives a crystal volume per protein weight (V M ) of 2.14 Å 3 Da À1 and a solvent content of 42.65%. A pseudo-translational symmetry is present in the P2 1 2 1 2 1 crystal form which is consistent with a filamentous arrangement of PstS in the crystal lattice.
Introduction
Pseudomonas aeruginosa (PA) bacilli are Gram-negative, facultative anaerobes and motile bacteria that cause infection and sepsis in many of the body's tissues. PA can form a biofilm that allows it to avoid eradication by antibiotics and the host immune system (Kerr & Snelling, 2009) . Several mechanisms facilitate PA adherence to surfaces and the formation of biofilm. These include the secretion of 'gluey' substances such as exopolysaccharides and the construction of filamentous extracellular arrays (Giraud et al., 2010) . Amongst the well characterized fibre-adhesive systems are the chaperone-usher (CU) fimbriae (Ruer et al., 2007) and the type IV pili (Craig et al., 2003) . Alverdy and coworkers identified a new PA filament-forming system which includes secretion of the PstS phosphate-binding protein from the bacterial periplasm (Zaborina et al., 2008; Shah et al., 2014) . They showed that PA strains in general and multidrug-resistant strains in particular secrete PstS through the alternative Hxc type II secretion system in response to low phosphate concentration, and that the secreted PstS participates in the construction of fibres that are described as 'appendages'. These appendages, which were identified using mass spectrometry and anti-PstS gold-labelled antibodies, were not present in strains in which either the PstS or Hxc genes were knocked-out (Zaborina et al., 2008) .
The Pst phosphate-transport system has a high (micromolar range) K m affinity towards inorganic phosphate (P i ) and is composed of five polypeptide chains (van Veen, 1997) , of which two are potential transmembrane permease subunits, designated PstA and PstC. Deletion of either PstA or PstC does not induce phosphate starvation, and it is therefore not clear whether they act as two separate homomers or rather as a heterodimer (Nikata et al., 1996) . Two identical ATPase subunits (PstB) that drive phosphate influx are constitutively attached to the intracellular side of the permease. The fifth Pst polypeptide, PstS, captures free P i in the periplasm and delivers it to the permease pore for transmembrane transport (Hsieh & Wanner, 2010) . PA PstS shares only about 18% identity with PstS orthologues that have available crystal structures, and their sequences cannot be readily aligned (Fig. 1) . It is therefore vital to obtain an independent high-resolution crystal structure of PA PstS in order to understand its roles in phosphate transport and biofilm formation. Here, we describe its expression, purification, crystallization and preliminary X-ray data collection.
Experimental procedures

Design of the PA PstS expression plasmid
PstS has a periplasmic phosphate-binding and transport activity, in which oxidation conditions may support the formation of disulfide bonds. As PA PstS contains two cysteine residues, we decided to use a periplasmic expression vector that will allow the complete folding of PstS. The insert (spanning residues 25 AIDPAL . . . IKELGL 323 ), containing the entire PA PstS (RefSeq NP_254056.1) excluding the signal peptide (first 24 residues), was generated by PCR amplification from the genomic DNA of the PA01 PA strain using the following primers: forward (5 0 -3 0 ), ATATGAATTCGGCGATCGACCC-GGCGCT; reverse (5 0 -3 0 ), GCGCAAGCTTCAGGCCCAGTTC-CTTGATCGC. The insert was ligated into a pET22 expression plasmid containing a pelB N-terminal signal peptide and a C-terminal hexahistidine tag. With the addition of the carboxy-terminal His-tag Sequence alignment of PstS from E. coli and PA. The complete sequence of PA PstS (accession No. NP_254056.1) was automatically aligned with the E. coli PstS protein (accession No. NP_418184.1) and with the sequence of the E. coli PstS crystal structure (PDB entry 2abh; Yao et al., 1996) using ClustalW. The phosphate-binding residues, as presented in the 2abh crystal structure, are highlighted in yellow. Note the overall poor homology between the E. coli and PA orthologues, in particular within the phosphatebinding residues. extension, the mature expressed PstS protein has a calculated weight of 33.6 kDa.
PstS expression and purification
Protein expression was performed in the Escherichia coli BL21 Tuner strain as described in Barak & Opatowsky (2013) . Transformed cells were grown for 3-4 h at 37 C in Terrific Broth medium containing 100 mg ml À1 ampicillin. Protein expression was induced with 200 mM IPTG over a 14 h period at 16 C. Cells were then harvested by centrifugation and immediately suspended in cold sucrose solution (20 mM Tris-HCl pH 8, 25% sucrose, 5 mM EDTA) for 15 min on ice to create a concentration gradient across the membrane. The cells were centrifuged and the pellet was dissolved in ice-cold lysis buffer (5 mM MgCl 2 , 40 ml 15 mg ml À1 lysozyme stock per gram of cells). After 30 min incubation on ice, the cell extract was centrifuged at 8000g for 20 min and the supernatant was equilibrated with buffer A (50 mM sodium phosphate buffer pH 7.4, 400 mM NaCl, 5% glycerol) by 1:4 dilution and loaded onto a pre-equilibrated nickel-chelate column with buffer A, washed and eluted with an imidazole gradient to buffer B (50 mM sodium phosphate buffer pH 7.4, 400 mM NaCl, 5% glycerol, 0.5 M imidazole). PstS-containing fractions were pooled, diluted 1:10(v:v) with buffer C (50 mM bis-tris pH 6.2), loaded onto a pre-equilibrated ion-exchange column (Source S, GE Healthcare), and washed and eluted with a gradient to buffer D (50 mM bis-tris pH 6.2, 1 M NaCl), where fractions 1-4 eluted in the range of 100-200 mM NaCl (Fig. 2) . The fractions were analyzed using SDS-PAGE, separately pooled according to their elution peak, concentrated to 15-30 mg ml
À1
, divided into aliquots and flash-frozen in liquid N 2 .
2.2.1. Attempted selenomethionine derivatization. In order to obtain experimental phase information, we pursued selenomethionine derivatization of PA PstS using the protocol of Van Duyne et al.
(1993) as we have successfully performed previously (Barak & Opatowsky, 2013; Opatowsky et al., 2004) . However, the selenomethionine-substituted PstS was predominantly insoluble and was not found in the periplasm, preventing its further purification.
Crystallization
PA PstS was screened against PEGRx HT, SaltRx HT, Index HT and Crystal Screen HT (Hampton Research, Aliso Viejo, California, USA) at 20 C in 96-well sitting-drop clear polystyrene microplates (Corning Life Sciences). The drop size was 2 ml, with a 1:1 sample:reservoir screen ratio. 1-6 weeks after setup, several crystal hits appeared (all from Source S elution peak 2) under the following conditions: (i) 0.1 M Tris pH 8.5, 2.2 M NaCl, (ii) 0.1 M bis-tris propane pH 7, 2.5 M ammonium sulfate, (iii) 0.1 M bis-tris propane pH 7, 2.4 M sodium malonate and (iv) 0.1 M bis-tris propane pH 7, 2.2 M malic acid pH 7.5, 0.1 M Tris pH 8, 30% PEG 2000. Crystallization conditions were refined using 24-well hanging-drop vapourdiffusion plates by varying pH values against precipitant and protein concentrations. Two crystallization conditions gave diffraction-grade crystals (Fig. 3) . These conditions contained reservoir solutions consisting of 25% PEG 3350, 0.1 M Tris pH 8 (designated crystal form 1) and 2.5 M sodium malonate, 0.1 M Tris pH 8 (designated crystal form 2). In both cases crystals appeared after about 8 weeks in 2 ml drops (protein:reservoir ratio of 1:1) and were harvested 1-3 weeks after appearance. While crystals of form 2 were directly harvested from the mother liquor and flash-cooled in liquid nitrogen, form 1 crystals were cryoprotected before harvesting by supplementing the precipitant content with 10% glycerol.
Native data collection and analysis
Diffraction data for the PstS crystals were measured on the tunable beamlines ID29 (de Sanctis et al., 2012) and ID23-1 at the European Synchrotron Radiation Facility (ESRF) under standard cryogenic conditions (Figs. 3b and 3c) to resolutions of 1.85 and 1.89 Å for crystal forms 1 and 2, respectively, and were processed and scaled using the XDSAPP software package (Krug et al., 2012) . The datacollection statistics are summarized in Table 1 .
Results and discussion
The PstS protein from PA has an apparent dual role in bacterial phosphate uptake and extracellular assembly of adhesion filaments. On several other occasions, crystal structure determination and crystal-packing analysis have revealed the molecular basis of bacterial fibre assembly (Garnett & Matthews, 2013; Garnett et al., 2012) , and we are therefore hopeful that crystal structure determination of PA PstS will help to understand its two seemingly unrelated functions. Here, we present the subcloning, expression, isolation, crystallization and crystallographic analysis of native PA PstS. As the periplasm is the primary cellular compartment for PstS activity, we decided to express PA PstS using the periplasmic expression vector pET22, thereby ensuring the formation of potential disulfide bonds. Periplasmic extraction was followed by metal-chelate and ionexchange chromatography, from which the protein eluted in four distinct fractions. The wide elution range and heterogeneous appearance of bands in some of the individual fractions indicate that PA PstS may be partially truncated. It is also possible that heterogeneity in conformation, maybe owing to partial phosphate binding, contributes to the behaviour of PstS when eluting from Source S. All four Source S elution peaks were screened for crystallization, but only peak 2 yielded diffracting crystals. X-ray data were collected to 1.85 and 1.89 Å resolutions for crystal forms 1 and 2, which belonged to space groups C222 1 and P2 1 2 1 2 1 , respectively. The P2 1 2 1 2 1 crystals exhibit pseudo-translational symmetry (Fig. 4) Native Patterson map section of a P2 1 2 1 2 1 PstS crystal. A strong off-origin peak indicating a pseudo-translational symmetry is marked by an arrow. native Patterson map (Winn et al., 2011) , and we surmise that the translational pseudo-symmetry of the crystal lattice may correlate to the arrangement of PstS in the PA adhesion filaments. We aim to obtain a molecular-replacement solution using the structures of phosphate-binding proteins from other bacteria (Vyas et al., 2003) for further structural interpretation.
